GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
This Quarter Return
+33.07%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$2.46B
AUM Growth
+$449M
(+22%)
Cap. Flow
+$6.32M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
34.46%
Holding
177
New
18
Increased
65
Reduced
70
Closed
24
Top Buys
| 1 |
Global E Online
GLBE
|
$31.3M |
| 2 |
CRCL
Circle Internet Group, Inc.
CRCL
|
$25.2M |
| 3 |
Magnite
MGNI
|
$23.9M |
| 4 |
Digital Turbine
APPS
|
$17.8M |
| 5 |
Klaviyo
KVYO
|
$16.1M |
Top Sells
| 1 |
StepStone Group
STEP
|
$20.5M |
| 2 |
ODDITY Tech
ODD
|
$15.1M |
| 3 |
KLC
KinderCare Learning Companies, Inc.
KLC
|
$14.2M |
| 4 |
Evolent Health
EVH
|
$12.9M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$12.8M |
Sector Composition
| 1 | Technology | 37.34% |
| 2 | Industrials | 18.28% |
| 3 | Healthcare | 12.27% |
| 4 | Financials | 9.42% |
| 5 | Consumer Discretionary | 9.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Soleno Therapeutics
SLNO
$3.56B
| $5.02M | 0.2% |
59,977
+27,486
| +85% | +$2.3M |
|
102
Zymeworks
ZYME
$1.07B
| $4.78M | 0.19% |
380,783
-26,806
| -7% | -$336K |
|
103
Certara
CERT
$1.69B
| $4.74M | 0.19% |
405,068
+170,108
| +72% | +$1.99M |
|
104
CorVel
CRVL
$4.47B
| $4.51M | 0.18% |
43,877
-12,316
| -22% | -$1.27M |
|
105
Topgolf Callaway Brands
MODG
$1.69B
| $4.48M | 0.18% |
556,559
+499,178
| +870% | +$4.02M |
|
106
Revolution Medicines
RVMD
$7.43B
| $4.48M | 0.18% |
121,780
-4,972
| -4% | -$183K |
|
107
Qualys
QLYS
$4.9B
| $4.35M | 0.18% |
30,416
-34,255
| -53% | -$4.89M |
|
108
Merus
MRUS
$5.04B
| $4.24M | 0.17% |
80,619
-15,101
| -16% | -$794K |
|
109
Credo Technology Group
CRDO
$21.6B
| $4.01M | 0.16% |
43,352
-18,632
| -30% | -$1.73M |
|
110
Arcus Biosciences
RCUS
$1.24B
| $3.99M | 0.16% |
490,613
+11,023
| +2% | +$89.7K |
|
111
Summit Therapeutics
SMMT
$17.5B
| $3.95M | 0.16% |
185,640
+61,113
| +49% | +$1.3M |
|
112
Boot Barn
BOOT
$5.5B
| $3.87M | 0.16% |
25,493
-6,909
| -21% | -$1.05M |
|
113
MoonLake Immunotherapeutics
MLTX
$3.78B
| $3.79M | 0.15% |
80,362
-61,858
| -43% | -$2.92M |
|
114
EXL Service
EXLS
$7.05B
| $3.78M | 0.15% |
86,430
+40,671
| +89% | +$1.78M |
|
115
Immunome
IMNM
$892M
| $3.65M | 0.15% |
392,751
-26,520
| -6% | -$247K |
|
116
BridgeBio Pharma
BBIO
$9.91B
| $3.57M | 0.15% |
+82,690
| New | +$3.57M |
|
117
Cellebrite
CLBT
$4.04B
| $3.48M | 0.14% |
217,573
-7,467
| -3% | -$119K |
|
118
Immunovant
IMVT
$2.91B
| $3.41M | 0.14% |
213,088
+40,772
| +24% | +$652K |
|
119
Onto Innovation
ONTO
$5.03B
| $3.41M | 0.14% |
33,758
-23,343
| -41% | -$2.36M |
|
120
Spire Global
SPIR
$274M
| $3.36M | 0.14% |
282,333
-856,842
| -75% | -$10.2M |
|
121
Natera
NTRA
$23B
| $3.27M | 0.13% |
19,371
-9,863
| -34% | -$1.67M |
|
122
EyePoint Pharmaceuticals
EYPT
$827M
| $3.21M | 0.13% |
+340,984
| New | +$3.21M |
|
123
AnaptysBio
ANAB
$630M
| $2.92M | 0.12% |
131,655
-14,836
| -10% | -$329K |
|
124
Columbus McKinnon
CMCO
$412M
| $2.82M | 0.11% |
184,535
-132,321
| -42% | -$2.02M |
|
125
Prothena Corp
PRTA
$452M
| $2.8M | 0.11% |
+461,082
| New | +$2.8M |
|